2009 Post-Interphex Showcase: Packaging Equipment & Supplies
2009 Post-Interphex Showcase: Packaging Equipment & Supplies
Packaging solution
The “NextBottle” package from Catalent and One World Design and Manufacturing Group is designed to improve patient compliance. The product’s dial mechanism dispenses one pill at a time and automatically reminds patients of the last day that a pill was taken.
Catalent Pharma Solutions, Somerset, NJ
www.catalent.com
tel. 866.720.3148
Transfer packaging for
prefillable syringes
“BD TSCF” packaging ensures the secure transfer of sterile prefillable syringe components into the pharmaceutical filling environment. The packaging is compatible with IDC “Biosafe” doors for aseptic filling machines within isolator or barrier systems. This packaging is part of the “BD SCF” global offer, which features expertise in sterile processing of preservative-free drugs; secure, reliable, easy-to-use systems; sterile, ready-to-fill; and drug master file and technical dossier.
BD Medical–Pharmaceutical Systems, Franklin Lakes, NJ
www.bdpharma.com
tel. 800.225.3310
Integrated blister line
The Giant1 integrated blister line fully responds to sophisticated production requirements worldwide. The line is an alternative for the timely production of small and medium-sized batches. The product produces as many as 350 blisters/min and 175 cartons/min. The machine provides flexible operation and changeover and easy cleaning.
IMA Group, Bristol, PA
www.ima.it
tel. 215.826.8500
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Cooperating With Our Customers Across the US
May 13th 2025Highlighting the importance for our clients to prepurchase multi-year maintenance contracts, in order to avoid their machines breaking or stopping to work suddenly and unexpectedly, to minimize the risk of interrupted production and emergency maintenance costs.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Large-Scale LNP Process Conversions: The many hurdles of LNP scale-up and what to consider
May 12th 2025Lipid nanoparticle (LNP) formulation development begins on a small scale, often with homemade or benchtop setups, using syringe pumps and easily accessible micro-mixing systems. Once a promising formulation has been identified, the next step is to transition to standardized large-scale impingement mixing systems, such as the high flow T-mixing pumps that were used to produce the COVID-19 vaccines (Sealy 2021). Formulators need to consider a number of factors when scaling up novel LNP systems. These include flow rates that affect LNP particles, solvent removal, risk factors when changing equipment, and the impact of tangential flow filtration sensitivity. In this technical note, we discuss these factors and what needs to be considered when developing a cost- and time efficient large-scale process.
